Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Institute for Clinical and Economic Review (ICER) is an independent non-profit research organization that evaluates the clinical and economic value of prescription drugs, medical tests, and other health care innovations. ICER is best known for producing rigorous evidence-based reports that include value-based price benchmarks, which are frequently used by payers, pharmaceutical companies, and policymakers to inform pricing and coverage decisions in the United States. The organization conducts public meetings to deliberate on its findings, aiming to improve patient access to high-value care while ensuring the sustainability of the healthcare system. By providing transparent assessments of comparative effectiveness and cost-effectiveness, ICER plays a pivotal role in the drug pricing landscape and the broader shift toward value-based healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute for Clinical.